Back to all bills
S 3209119th CongressIn Committee
NOPAIN for Veterans Act
Introduced: Nov 19, 2025
Sponsor: Sen. Capito, Shelley Moore [R-WV] (R-West Virginia)
Standard Summary
Comprehensive overview in 1-2 paragraphs
This bill amends title 38, United States Code, to require the Secretary of Veterans Affairs to include non-opioid pain management drugs or biological products in the VA's national formulary within one year of FDA approval or eligibility for Medicare payment, whichever is earlier. It defines non-opioid pain management drugs as FDA-approved products that reduce postoperative pain, produce postsurgical analgesia, or treat acute pain without acting on opioid receptors. Implementation must occur within 90 days of enactment, and no funds from the Cost of War Toxic Exposures Fund may be used.
Key Points
- 1Requires VA to include non-opioid pain management drugs in national formulary
- 2Timeline: within one year of FDA approval or Medicare payment eligibility
- 3Defines non-opioid pain management drugs as FDA-approved products for pain reduction
- 4Implementation deadline: 90 days after enactment
- 5Prohibits use of Cost of War Toxic Exposures Fund for implementation
- 6Aims to expand access to non-opioid pain treatment options for veterans
Impact Areas
Veterans AffairsPain managementOpioid crisisVeterans healthcarePharmaceutical policyFederal healthcare programs
Generated by kwaipilot/kat-coder-pro:free on Dec 6, 2025